Companies / EyePoint, Inc.
EyePoint, Inc.
Financials · FY2025
Ownership
86.2M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 0.69% | 594,454 |
| Institutions | 97.30% | 83,882,471 |
| Public float | 2.01% | 1,735,213 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Lurker NancyDirector | 0.34% | 294,346 |
Duker Jay S.CEOPresident and CEO · Director | 0.21% | 178,417 |
Elston GeorgeChief Financial Officer | 0.14% | 121,691 |
Ribeiro RamiroChief Medical Officer | 0.00% | 0 |
Ando GoranDirector | — | — |
Dicicco Wendy FDirector | — | — |
Duty StuartDirector | — | — |
Hassan FredDirector | — | — |
Landis John B.Director | — | — |
Sanders Reginald J.Director | — | — |
Institutional holders 169
View all →| Holder | Value | % of shares |
|---|---|---|
| $151.00M | 9.59% | |
| $143.01M | 9.08% | |
| $106.72M | 8.66% | |
| $90.93M | 5.77% | |
| $88.10M | 5.59% | |
| $73.08M | 6.58% | |
| $67.44M | 4.28% | |
| $65.27M | 4.14% | |
| $46.42M | 4.18% | |
| $42.54M | 3.83% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | Trim | Common stock | $-18.05M | -1.4M -29.79% | 3,300,000 3.83% of shares | medium |
| Q1 2026 as of | Orbimed Advisors LLC 13F manager | Trim | Common stock | $-18.04M | -1.4M -56.69% | 1,069,147 1.24% of shares | medium |
| Q1 2026 as of | Balyasny Asset Management L.P. 13F manager | Add | Common stock | $10.87M | +843K +141.65% | 1,438,737 1.67% of shares | medium |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common stock | $-10.86M | -594K -58.82% | 416,100 0.48% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $9.66M | +675K +9.95% | 7,463,197 8.66% of shares | medium |
| Q1 2026 as of | Janus Henderson Group PLC 13F manager | Add | Common stock | $8.55M | +663K +22.58% | 3,601,168 4.18% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common stock | $7.47M | +523K +28.49% | 2,357,545 2.73% of shares | medium |
| Q1 2026 as of | Federated Hermes Inc 13F manager | Trim | Common stock | $-4.48M | -348K -5.78% | 5,669,589 6.58% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| TCG Crossover GP II, LLC | Passive13G/A | — |
| Paradigm BioCapital Advisors LP | Passive13G | — |
| Adage Capital Management, L.P. | Passive13G/A | — |
| Paradigm BioCapital Advisors LP | Passive13G/A | — |
| Commodore Capital LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| EYPT | — | 30233G209 |